Delivery Order SPE2DX15D1113-SPE2DX24FBJWA

Award Date 9/24/24
Potential Completion Date 9/25/24
Potential Value $3.5K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,971.76 firm fixed-price delivery order is for the supply of 4 mg Ondansetron Orally Disintegrating Tablets, which are used to treat nausea and vomiting. The award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,249.10 firm fixed-price delivery order is for the provision of 4 mg ondansetron orally disintegrating tablets, a medication used to prevent nausea and vomiting. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,254.01 firm fixed-price delivery order covers the supply of 4 mg Ondansetron orally disintegrating tablets, a medication used to prevent nausea and vomiting. The contract has an ultimate completion date of February 2, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,323.09 firm fixed-price delivery order is for the supply of 4 mg ondansetron orally disintegrating tablets, a medication used to prevent nausea and vomiting. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,555.97 firm-fixed-price delivery order is for the supply of 4 mg Ondansetron Orally Disintegrating Tablets, a medication used to treat nausea and vomiting. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,122.54 delivery order is for the supply of 4 mg ondansetron orally disintegrating tablets, a medication used to prevent nausea and vomiting. The contract is a firm-fixed-price delivery order with a period of performance through March 26, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,174.80 firm fixed-price delivery order is for the supply of 4 mg Ondansetron Orally Disintegrating Tablets, a medication used to prevent nausea and vomiting. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,798.33 firm fixed-price delivery order is for the supply of 4 mg ondansetron orally disintegrating tablets, a medication used to treat nausea and vomiting. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as...
This federal contract award from the Defense Logistics Agency (DLA) was granted to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,528.76 firm-fixed-price delivery order is for the supply of ondansetron ODT 4 mg tablets, which are used to treat nausea and vomiting. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,290.17 delivery order contract is for the supply of ondansetron orally disintegrating tablets, a medication used to treat nausea and vomiting. The contract is awarded under Amerisourcebergen's existing $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
  • SPE2DX15D1113
    Indefinite Delivery Contract
  • SPE2DX15D1113-SPE2DX24FBJWA
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $3,536.43 firm fixed-price delivery order is for the supply of 4 milligram Ondansetron orally disintegrating tablets, a medication commonly used to treat nausea and vomiting. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables the DLA to efficiently procure a comprehensive range of medical commodities from AmerisourceBergen to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation, and the ultimate completion date is September 25, 2024.

Generated 12/24/24, 9:36 AM